These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 15159474)

  • 1. Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden.
    Simpson EP; Henry YK; Henkel JS; Smith RG; Appel SH
    Neurology; 2004 May; 62(10):1758-65. PubMed ID: 15159474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS).
    Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Lancero M; Narvaez A; McGrath MS
    J Neuroimmunol; 2006 Oct; 179(1-2):87-93. PubMed ID: 16857270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased levels of MIP-1α in CSF and serum of ALS.
    Yang X; Gao L; Wu X; Zhang Y; Zang D
    Acta Neurol Scand; 2016 Aug; 134(2):94-100. PubMed ID: 26427609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal synthesis of monocyte chemoattractant protein-1 (MCP-1) in amyotrophic lateral sclerosis: further evidence for microglial activation in neurodegeneration.
    Wilms H; Sievers J; Dengler R; Bufler J; Deuschl G; Lucius R
    J Neuroimmunol; 2003 Nov; 144(1-2):139-42. PubMed ID: 14597108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
    Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
    Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
    Henkel JS; Engelhardt JI; Siklós L; Simpson EP; Kim SH; Pan T; Goodman JC; Siddique T; Beers DR; Appel SH
    Ann Neurol; 2004 Feb; 55(2):221-35. PubMed ID: 14755726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.
    Smith RG; Henry YK; Mattson MP; Appel SH
    Ann Neurol; 1998 Oct; 44(4):696-9. PubMed ID: 9778272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bFGF in the CSF and serum of sALS patients.
    Gong Z; Gao L; Guo J; Lu Y; Zang D
    Acta Neurol Scand; 2015 Sep; 132(3):171-8. PubMed ID: 25631037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of MCP-1 and MCP-1/VEGF ratio in cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Nagata T; Nagano I; Shiote M; Narai H; Murakami T; Hayashi T; Shoji M; Abe K
    Neurol Res; 2007 Dec; 29(8):772-6. PubMed ID: 17672928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cerebrospinal fluid levels of cytokines monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1β (MIP-1β) in patients with amyotrophic lateral sclerosis.
    Martínez HR; Escamilla-Ocañas CE; Camara-Lemarroy CR; González-Garza MT; Moreno-Cuevas J; García Sarreón MA
    Neurologia (Engl Ed); 2020 Apr; 35(3):165-169. PubMed ID: 29029824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal upregulation of granulocyte colony stimulating factor and its neuroprotective actions on motor neurons in amyotrophic lateral sclerosis.
    Tanaka M; Kikuchi H; Ishizu T; Minohara M; Osoegawa M; Motomura K; Tateishi T; Ohyagi Y; Kira J
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):816-25. PubMed ID: 16896315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor-A (VEGF-A) and chemokine ligand-2 (CCL2) in amyotrophic lateral sclerosis (ALS) patients.
    Gupta PK; Prabhakar S; Sharma S; Anand A
    J Neuroinflammation; 2011 May; 8():47. PubMed ID: 21569455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression.
    Andrés-Benito P; Domínguez R; Colomina MJ; Llorens F; Povedano M; Ferrer I
    Aging (Albany NY); 2018 Sep; 10(9):2367-2382. PubMed ID: 30215603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders.
    Di Domenico F; Tramutola A; Butterfield DA
    Free Radic Biol Med; 2017 Oct; 111():253-261. PubMed ID: 27789292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalase activity in blood fractions of patients with sporadic ALS.
    Golenia A; Leśkiewicz M; Regulska M; Budziszewska B; Szczęsny E; Jagiełła J; Wnuk M; Ostrowska M; Lasoń W; Basta-Kaim A; Słowik A
    Pharmacol Rep; 2014 Aug; 66(4):704-7. PubMed ID: 24948075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF levels in CSF and serum in mild ALS patients.
    Gao L; Zhou S; Cai H; Gong Z; Zang D
    J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma biomarkers associated with ALS and their relationship to iron homeostasis.
    Mitchell RM; Simmons Z; Beard JL; Stephens HE; Connor JR
    Muscle Nerve; 2010 Jul; 42(1):95-103. PubMed ID: 20544912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 4-hydroxynonenal and neurodegenerative diseases.
    Zarkovic K
    Mol Aspects Med; 2003; 24(4-5):293-303. PubMed ID: 12893007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
    Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
    Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.